Status:
COMPLETED
Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Intra-dialytic Hypotension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Kidney failure can result from a variety of conditions and can be temporary or permanent. Hemodialysis is available as a replacement treatment to perform the work that the kidneys normally do. However...
Eligibility Criteria
Inclusion
- Renal failure requiring intermittent hemodialysis initiation; adult patients aged over 18 years; written informed consent
Exclusion
- Hyponatremia \<130 mmol/L; acute myocardial infarction or stroke in previous 7 days; cardiac transplant; ventricular arrhythmia; unstable angina; use of pressors/midodrine; enrollment in conflicting research study; institutionalized individuals; pregnancy; prisoners; documented allergy to mannitol
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01520207
Start Date
May 1 2012
End Date
December 1 2018
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115